[an error occurred while processing this directive]

HEREDITAS ›› 2009, Vol. 31 ›› Issue (3): 255-260.doi: 10.3724/SP.J.1005.2009.00255

• 研究报告 • Previous Articles     Next Articles

Aneuploid analysis of chromosomes 3, 8, 10, 20 and Y in eso-phageal squamous cell carcinoma

KANG Wei1, 2;AO Han-Qing2;FANG Li-Li2;AI Yan2;AN Ya-Ling2;U Xin2;ANG Yu2;JIA Xue-Mei1;ANG Ming-Rong2   

  1. 1. Department of Histology and Embryology, Anhui Medical University, Hefei 230032, China;
    2. State Key Laboratory of Molecular Oncology, Cancer Institute (Hospital), Peking Union Medical College and Chinese Academy of Medical Sciences, Beijing 100021, China
  • Received:2008-11-26 Revised:2008-12-15 Online:2009-03-10 Published:2009-03-10

Abstract: Although the diagnostic and therapeutic modalities of esophageal squamous cell carcinoma (ESCC) have been improved considerably, the five-year survival rate is still not satisfied. To detect the numberial aberrations of the chromo-somes in ESCC, fluorescence in situ hybridization (FISH) was performed on interphase nuclei prepared from 220 esophag-eal carcinoma tissues with specific centromeric probes for chromosomes 3, 8, 10, 20 and Y. The main aberrations of the euchromosomes was chromosome gain, including trisome, tetrasome, and polysome. The gain rates of the four euchromo-some were 84.9%, 77.5%, 63.7% and 83.2%, and the frequencies of polysome for each euchromosome were 24.6%, 34.9%, 23.4% and 31.7%, respectively. Loss of chromosome Y was observed in 61.2% of male patients. The combination of the four chromosome probes 3, 8, 10 and 20 detected 74.5% of ESCC and the combination of 3, 8, 20 and Y detected 85.0%. These results indicated that both sets of the four centromeric probe combinations provide candidate biomarkers for the di-agnosis of esophageal squamous cell carcinoma.